Full Year 2020 Oasmia Pharmaceutical AB Earnings Call Transcript
Welcome to the Oasmia Pharmaceutical Q4 report. With us today, we have CEO, Francois Martelet; acting CFO, Robert Maiorana. (Operator Instructions)
I'll now hand over to Francois. Please go ahead.
()-
Thank you very much, and good morning, everyone. Pleasure to be here with you today to provide an update on our Q3 and year-end results.
So just would like to say that from January 1 of this year, Oasmia will change the use of the calendar year as its financial year. So to make it -- this happen, this presentation does include an abbreviated financial year covering the period from May 1 until December 31, 2020, that means 8 months. And the comparative figures for the previous year reports the same period in -- of last year, which means 2019. So I think it's important for you to understand that.
All right. So moving to Slide 2. This is the forward-looking statements.
And on Slide 3. So -- as you heard -- so today, I will be joined by Robert.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |